Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call
29. Juli 2024 08:30 ET
|
Neuronetics
MALVERN, Pa., July 29, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Aetna Policy Update Expands TMS Availability for Adolescents With Depression
22. Juli 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults
11. Juli 2024 08:36 ET
|
Neuronetics
MALVERN, Pa., July 11, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents
10. Juli 2024 08:32 ET
|
Neuronetics
MALVERN, Pa., July 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar® Launches Better Me Provider Program Nationwide
01. Juli 2024 08:02 ET
|
Neuronetics
MALVERN, Pa., July 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting
13. Juni 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., June 13, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference
23. Mai 2024 08:30 ET
|
Neuronetics
MALVERN, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
15. Mai 2024 07:32 ET
|
Neuronetics
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Reports Record First Quarter 2024 Financial and Operating Results
07. Mai 2024 07:30 ET
|
Neuronetics
MALVERN, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03. Mai 2024 16:30 ET
|
Neuronetics
MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...